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In a follow-up of 1208001 women aged 20–74 years, no significant association was found between twin births (112 cases) and risk,
though those with twin girls had a non-significantly higher risk than those with singleton births; among the latter, those with girls only
had a higher risk of endometrioid tumours (incidence rate ratio 1.35; 95% confidence interval 1.03–1.76, based on 475 cases) than
women with boys only.
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The protective effect of pregnancies on the risk of epithelial
ovarian cancer is usually explained by their influence on lifetime
number of ovulations (Risch, 1998). Women prone to have
multiple births have a higher level of follicle-stimulating hormone
(Bulmer, 1970; Corney et al, 1981; Risch, 1998) and may also
ovulate more often (Allen, 1981), possibly leading to an increased
risk (Risch, 1998; Lukanova and Kaaks, 2005). Certain maternal or
pregnancy-related factors associated with twinning may however
be related to a reduced risk (Risch, 1998) though only a slightly
lower or similar risk has been reported in twin compared to
singleton mothers (Wyshak et al, 1983; Olsen and Storm, 1998;
Lambe et al, 1999; Whiteman et al, 2000; Titus-Ernstoff et al, 2001;
Neale et al, 2004, 2005).
Hormones may play a role in ovarian cancer carcinogenesis
(Riman et al, 1998; Risch, 1998; Lukanova and Kaaks, 2005).
Maternal hormone levels have been found to be higher in
pregnancies involving twins (TambyRaya and Ratnam, 1981;
Risch, 1998; Storgaard et al, 2006). The levels of oestrogens,
androgens and human chorionic gonadotropin (hCG) seem to
differ by sex of the fetus in singleton gestations (Robinson et al,
1977; Forest et al, 1980; Haning et al, 1989; Cerhan et al, 2000; Luke
et al, 2005). A different risk pattern according to sex of children
may therefore throw light on alternative hormone-related hypo-
theses, but few studies have focused on this issue.
We have examined associations between twin births, sex of
children and the risk of ovarian cancer in a large cohort of parous
Norwegian women.
MATERIALS AND METHODS
The present study includes Norwegian women born in the period
1925-1979, as recorded in the national population register. The
study population comprised 1208001 parous women, contributing
a total of 27634403 person-years at risk in the age interval 20–74
years during follow-up until 1st January, 2000. The mean follow-up
time was 22.9 years, range 1 month–45 years. A total of 28911
women had experienced a twin birth; 354 of these had two twin
births and five had three. Women with higher plurality of a
multiple birth (n¼461) were excluded. Information on reproduc-
tive history (date of birth for each live born child) and cancer
diagnoses was assessed through national registers.
A total of 5606 women were diagnosed with ovarian cancer (ICD
7th Revision, code 175). Of these, 5204 (92.8%) were classified as
invasive epithelial ovarian cancer, 291 (5.2%) as non-epithelial
ovarian cancer, whereas 111 (2.0%) had no valid histological code.
Borderline tumours were not considered. Separate analyses were
performed for epithelial and non-epithelial ovarian cancer, and by
histological subtype (Table 1). A woman was withdrawn from the
risk set at date of diagnosis of any type of ovarian cancer.
Statistical analysis
A log-linear Poisson regression model of person–years at risk
(Breslow and Day, 1987) was applied. Attained age was considered
as timescale (categorical variable, 1-year intervals). The variables
representing parity (number of full term births) and different birth
characteristics were treated as time-dependent categorical vari-
ables. A twin birth was identified through identical birth dates of
siblings. Birth-cohort, maternal age at first and last (most recent)
childbirth, were all considered as categorical variables in 5-year
intervals.
Tabulation of individual records into person–years tables and
Poisson regression analyses of person–years at risk, with
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ratios (IRR) and likelihood ratio tests were performed by means of
the EPICURE programme package (Preston et al, 1996).
RESULTS
No significant association was found between twin births and risk
of epithelial ovarian cancer (112 cases), but women with twin
girls had a slightly higher risk than women with singletons only,
whereas women with twin boys or twins of both sexes, had a
slightly lower risk (Table 2). The elevated risk associated with twin
girls was more pronounced before age 45 years, but the interaction
test did not reach statistical significance (Table 2).
The association with sex of twins reached statistical significance
for mucinous tumours (P¼0.019, test for heterogeneity); women
with twin girls had almost twice the risk of singleton mothers
(IRR¼1.67, 95% confidence interval (CI)¼0.98–2.91, 13 of 20
cases), whereas with twin boys the risk was lower (IRR¼0.26, 95%
CI¼0.07–1.04; two cases only). An adverse effect of twin girls
was also seen for serous tumours before age 45 years (IRR¼2.08,
95% CI¼1.15–3.77 and IRR¼0.72, 95% CI¼0.40–1.29 in women
below and above age 45 years, respectively; P¼0.10, test for
interaction). Twin mothers had a slightly reduced risk of
endometrioid tumours (IRR¼0.52, 95% CI¼0.23–1.16); numbers
were too low to discriminate by sex of the twins (Table 1). Twin
mothers had a higher risk of non-epithelial ovarian cancer
(IRR¼1.79, 95% CI¼0.98–3.28), especially stromal tumours
(IRR¼3.97, 95% CI¼2.00–7.86).
In women with singleton births, no association was found
between sex of children and the risk of epithelial ovarian cancer
(Table 2). However, women with girls only had significantly higher
risk of endometrioid tumours than women with boys only
(IRR¼1.35, 95% CI¼1.03–1.76), whereas women with both girls
and boys had a rather similar risk (IRR¼1.16, 95% CI¼0.88–
1.52). The adverse effect of having girls only was more pronounced
in women with at least three children (IRR values of 1.34, 1.28 and
1.61 in women with one, two and Xthree children, respectively),
and in women above age 45 years (IRR values of 1.23 and 1.40 in
women below and above age 45 years, respectively). No consistent
association was seen between sex of children and other histological
subtypes (results not shown).
DISCUSSION
This large cohort study did not show any overall association
between twin births and the risk of epithelial ovarian cancer, but
women with twin girls seemed to have a higher risk than singleton
mothers. The increased risk was particularly pronounced for
mucinous tumours, and serous tumours before age 45 years; a
slightly lower risk was seen at older ages. Sex of children in
singleton births was associated with the risk of endometrioid
tumours only; women with girls only had the highest risk.
Previous studies have found a lower or rather similar risk of
epithelial ovarian cancer in twin compared to singleton mothers
(Olsen and Storm, 1998; Lambe et al, 1999; Whiteman et al, 2000;
Titus-Ernstoff et al, 2001; Neale et al, 2004, 2005), but few have
focused on sex of the twins, or performed subgroup analyses. One
study based on pooled data from eight case–control studies
(Whiteman et al, 2000) found an adverse effect of twinning in
relation to mucinous tumours, but a protective effect in relation to
non-mucinous tumours. However, no information was given on
the sex of the twins. Another study (Lambe et al, 1999) found a
more pronounced reduction in risk in mothers with twins of
opposite sex than same-sex twins; no histology-specific results
were presented.
Consistent with our finding for endometrioid tumours, one
previous study (Gierach et al, 2006) found that women with girls
only had higher risk of epithelial ovarian cancer than women with
boys only, or boys and girls. In another study (Olsen and Storm,
Table 1 Distribution of histological subtype in ovarian cancer patients
a,
total and in twin and singleton mothers, respectively
Total
Twin
mothers
Singleton
mothers
No. (%) No. (%) No. (%)
Epithelial 5204 (92.8) 112 (88.2) 5092 (92.9)
Serous 2639 (47.1) 61 (48.0) 2578 (47.1)
Mucinous 1020 (18.2) 20 (15.7) 1000 (18.3)
Endometrioid 481 (8.6) 6 (4.7) 475 (8.7)
Clear cell 243 (4.3) 5 (3.9) 238 (4.3)
Other/unspecified
adenocarcinoma
821 (14.6) 20 (15.7) 801 (14.6)
Non-epithelial 291 (5.2) 11 (8.7) 280 (5.1)
Stromal 108 (1.9) 9 (7.1) 99 (1.8)
Germ cell 109 (1.9) 1 (0.8) 108 (2.0)
Sarcomas 74 (1.3) 1 (0.8) 73 (1.3)
Unspecified 111 (2.0) 4 (3.1) 107 (2.0)
Total 5606 (100) 127 (100) 5479 (100)
aAged 20–74 years at date of diagnosis.
Table 2 Incidence rate ratios (IRR with 95% confidence interval) of
epithelial ovarian cancer by twin births and sex of the twins, and by sex of
children in women with singleton births only
a
No. of
cases
P–year
( 10
4)
IRR (95%
CI) P-value
b
Twin birth 0.39
Never (singletons only) 5092 2706.2 1.00 (ref.)
Ever 112 57.2 0.92 (0.76–1.11)
By sex of the twins
c 0.10
Two boys 33 19.3 0.82 (0.58–1.16)
Two girls 49 19.4 1.21 (0.91–1.61)
Boy and girl 30 18.5 0.73 (0.51–1.05)
Within age groups (year)
20–44
Two boys 9 12.2 0.83 (0.43–1.60)
Two girls 20 12.3 1.83 (1.18–2.85)
Boy and girl 9 11.2 0.88 (0.46–1.69)
45–54
Two boys 11 41.5 0.76 (0.42–1.38)
Two girls 12 41.5 0.83 (0.47–1.46)
Boy and girl 8 41.7 0.55 (0.27–1.10)
55–74
Two boys 13 29.5 0.88 (0.51–1.51)
Two girls 17 29.4 1.13 (0.70–1.83)
Boy and girl 13 31.6 0.81 (0.47–1.39)
P-value, test for
interaction
d
0.20
Singleton births, sex of
children
0.96
Boys only 1163 662.9 1.00 (ref.)
Girls only 1339 735.7 1.02 (0.94–1.11)
Boys and girls 2590 1298.3 1.00 (0.92–1.08)
aResults based on Poisson regression analysis of person–years (P–year) at risk,
adjusted for attained age, birth-cohort, number of births, and maternal age at first
and most recent birth.
bTest for heterogeneity.
cWomen with singleton births as
reference group.
dTest for heterogeneity in risk estimates in women above and below
age 45 years.
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developed ovarian cancer was similar to that in infants with
mothers without such a diagnosis.
There is growing evidence that oestrogens play a role in ovarian
cancer carcinogenesis, as well as tumour progression (Mink et al,
2002; Cunat et al, 2004; Riman et al, 2004). The hCG level is higher
during female than male gestations (Robinson et al, 1977; Haning
et al, 1989; Cerhan et al, 2000; Luke et al, 2005) and hCG is
involved in oestrogen production during pregnancy (Risch, 1998).
Moreover, the hCG level has been found to be higher in twin than
in singleton pregnancies (Haning et al, 1989; Luke et al, 2005), and
highest when both twins are girls (Steier et al, 1989). A potential
increased risk of mucinous and serous tumours in women with
twin girls, and an increased risk of endometrioid tumours in
women with girls only, may thus be related to an adverse effect of
oestrogens, acting either at early or later stages of carcinogenesis
during pregnancy. Oestrogen receptors have been found both in
endometrioid, serous and mucinous ovarian tumours (Risch, 1998;
Gadducci et al, 2004; Auranen et al, 2005; Lee et al, 2005), and also
in normal ovarian surface epithelial cells (Cunat et al, 2004;
Auranen et al, 2005). The apparent reduced risk of endometrioid
tumours in twin mothers, however, is more likely explained by
other, possibly maternal factors (Risch, 1998).
In summary, the present results suggest a complex relationship
between twin births, sex of children and ovarian cancer risk,
including a heterogeneity according to woman’s age, as well as
histological subtype. Women with twin girls or women with
daughters only, seem to have an increased risk of certain
histological types, whereas pregnancies involving a male foetus
showed either no association, or a reduced risk. Maternal, as well
as pregnancy-related factors, may explain these epidemiological
findings. Further studies are needed to exclude the role of chance.
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